Due to Mr. X's long battle with this, the obit suggests giving to the Michael J. Fox Foundation to continue the fight
Whether they [Novartis] will continue to review your proposal is of course up to ... 
efforts, to give its own trial a lead in the race to prove nilotinib's value.